Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.

Structural changes of the androgen receptor (AR) may contribute to the development of resistance to endocrine therapy in prostatic carcinoma. We have isolated AR cDNA fragments from seven tumor specimens derived from patients with advanced metastatic prostatic tumors. In one specimen obtained from a...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Zoran Čulig, Alfred Hobisch, Marcus V. Cronauer, Andrew C.B. Cato, A Hittmair, Christian Radmayr, Julia Eberle, G. Bartsch, Helmut Klocker
Médium: Artigo
Jazyk:angličtina
Vydáno: 1993
On-line přístup:https://doi.org/10.1210/mend.7.12.8145761
https://academic.oup.com/mend/article-pdf/7/12/1541/9079613/mend1541.pdf
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!